Inference for treatment effect parameters in potentially misspecified high-dimensional models
From MaRDI portal
Recommendations
- Optimal Statistical Inference for Individualized Treatment Effects in High-Dimensional Models
- Debiased Inference on Treatment Effect in a High-Dimensional Model
- Inference of Heterogeneous Treatment Effects using Observational Data with High-Dimensional Covariates
- Model-assisted inference for treatment effects using regularized calibrated estimation with high-dimensional data
- High-dimensional inference in misspecified linear models
- Inference on treatment effects after selection among high-dimensional controls
- Inference and Estimation for Random Effects in High-Dimensional Linear Mixed Models
- Higher order inference on a treatment effect under low regularity conditions
- Estimation and inference of treatment effects with L₂-boosting in high-dimensional settings
- Treatment Effect Estimation Under Additive Hazards Models With High-Dimensional Confounding
Cited in
(13)- Doubly robust semiparametric inference using regularized calibrated estimation with high-dimensional data
- The costs and benefits of uniformly valid causal inference with high-dimensional nuisance parameters
- High-dimensional inference in misspecified linear models
- Multiply robust estimation of the average treatment effect with missing outcomes
- Estimation and inference of treatment effects with L₂-boosting in high-dimensional settings
- Model-Assisted Inference for Covariate-Specific Treatment Effects with High-dimensional Data
- Debiased inverse propensity score weighting for estimation of average treatment effects with high-dimensional confounders
- Improve efficiency of doubly robust estimator when propensity score is misspecified
- Doubly-robust inference for conditional average treatment effects with high-dimensional controls
- A stableness of resistance model for nonresponse adjustment with callback data
- Doubly Robust Augmented Model Accuracy Transfer Inference with High Dimensional Features
- Optimising precision and power by machine learning in randomised trials with ordinal and time-to-event outcomes with an application to COVID-19
- Joint estimation of sparse and dense components through structured iteration
This page was built for publication: Inference for treatment effect parameters in potentially misspecified high-dimensional models
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5022103)
